• Downloads
  • Contact Us
  • Directions
  • Deutsch Deutsch German de
  • English English English en
  • 简体中文 简体中文 Chinese (Simplified) zh-hans
Epitype GmbH
  • Products
  • About us
    • Management
    • Team
    • Research projects
    • Publications
    • Press
    • Jobs
  • Contact
    • Directions
    • Contact Us
  • News / Blog
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

Cervical Cancer and Uterine (Body) Cancer – What is the Difference?

Blog
Cervical CancerBlamb/Shutterstock.com

Although cervical cancer and uterine (body) cancer develop only a few centimetres apart, there are big differences in the cause of the disease. Therefore, the fields of research and treatment are also fundamentally different. This article will explain the differences, for a better understanding.

First, anatomy, in order to be able to better classify where both types of cancer originate: the uterus consists of the cervix, which ends at the lower end in the uterine orifice. The uterine body (corpus uteri) is connected to the upper end of the cervix. Cervical cancer develops in the cervix, only a few centimetres away from the uterus, where uterine (body) cancer develops.

Uterine Cancer – Factors, Occurrence and Symptoms

Uterine cancer (endometrial carcinoma, womb cancer, or corpus carcinoma) usually originates from the cells of the uterine mucosa. There is the very common oestrogen-dependent type I and the rare oestrogen-independent type II. Hereditary factors, overweight, diabetes and a long oestrogen influence (mostly caused by hormonal imbalances) favour uterine cancer. Uterine cancer usually occurs in older women. The average age is 69, and there is no regulated screening, as there is no cost-effective and reliable procedure for early detection.

While cervical cancer does not necessarily have symptoms, or they appear very late, uterine cancer usually has unusual bleeding at an early stage. If the patient goes to the doctor immediately and the bleeding is indeed a symptom of uterine cancer, there is a good chance of recovery. The uterus, fallopian tubes and ovaries may then be removed by surgery. If the cancer is more advanced, further treatment is necessary.

Cervical Cancer – Cause, Prevention, Treatment

Conditions are completely different in the case of cervical cancer: this disease develops over many years as a result of infection with certain strains of human papillomavirus (HPV). Through regular preventive care, preliminary stages, so-called dysplasias, can be detected and treated. Preliminary stages do not necessarily lead to the outbreak of cervical cancer. They may also regress. In any case, they must be observed. If a procedure is necessary, it is usually the so-called conisation, which aims at removing the carcinoma completely. As patients are often women of childbearing age, it is important to remove as little of the cervix as possible to avoid complications in possible later pregnancies.

Although cervical cancer (cervical carcinoma) and uterine cancer (endometrial carcinoma) develop only a few centimetres apart, they are two completely different types of cancer with different courses, symptoms and treatments. Particularly, cervical cancer is preventable: anyone who goes for regular cervical check and is vaccinated has a very low risk of developing it.

In summary, the following table provides an overview of both types of cancer:

 

Cervical cancer (cervical carcinoma) Uterine cancer (endometrial carcinoma)
Frequency 500.000 worldwide 382 069 worldwide
Average age of patients 34 (for early-stage carcinoma)

53 (for advanced carcinoma that has already spread to other tissue)

69
Main cause/trigger Human papillomaviruses (HPV) Genetic factors, overweight, diabetes, hormonal imbalances
Symptoms Not necessarily. There may be pain during sexual intercourse, discharge or bleeding (in late stages) Bleeding (in early stages), other symptoms occur in later stages
Prevention HPV vaccination, screenings Healthy lifestyle
Early detection Organized screening, regulated by law No screening program. Examination (ultrasound or uterine endoscopy) can be performed as an individual health service (IGeL)
Duration of development Over a number of years
Treatment Observation and tests for preliminary stages, conisation for cancer (surgical procedure in which a conical piece of the cervix is removed) Surgical procedure (removal of the uterus, fallopian tubes and ovaries), additional treatment in case of advanced stages
31. July 2018/by Admin Spinger
Tags: cervical cancer
Share this entry
  • Share on WhatsApp
https://www.epitype.de/wp-content/uploads/2020/05/shutterstock_195843548_blog.jpg 607 845 Admin Spinger https://www.epitype.de/wp-content/uploads/2025/09/epitype_website-logo-300x130.png Admin Spinger2018-07-31 10:06:532020-07-02 10:09:07Cervical Cancer and Uterine (Body) Cancer – What is the Difference?
You might also like
Theresa Erler im Labor der oncgnostics GmbHEberhard Schorr / oncgnostics GmbH Looking back on a successful year of research
cobas Z480 Analyzer von Roche Diagnostics oncgnostics GmbH Oncgnostics GmbH Presents New Clinical Data on GynTect® Precision Diagnostics at EUROGIN 2018
Medirex team in Bratislava Reliable test for cervical cancer triage now available in Slovakia and the Czech Republic: Biotech company oncgnostics concludes an exclusive partnership with the MEDIREX group
Dr. Xia Xiaokai and Dr. Alfred Hansel, chairman of oncgnostics GmbH. In the background: Yang Xiaoming, chairman of CNBG, Wolfgang Tiefensee, Thuringia's Minister for economics, Dr. Michael Brandkamp, chairman of the High-Tech-Gründerfonds sowie Peter Haug, oncgnostics. photo: Christoph Worsch GynTect soon available in China: – oncgnostics grants exclusive license for GynTect to the Chinese SINOPHARM subsidiary CJMT – approval for the Chinese market planned
team of oncgnostics celebrates 10th anniversary Cancer prevention remains a matter of the heart: Biotech company oncgnostics celebrates 10th anniversary
Portugal Partnership Test for Uterine Cancer in Portugal: Biotech Firm oncgnostics Grants Exclusive Licence for Cancer Screening Test
Das oncgnostics-Teamoncgnostics GmbH Cervical Cancer Screening: oncgnostics Closes further Investment Round
cobas Z480 Analyzer von Roche Diagnostics oncgnostics GmbH Early detection test GynTect® now available for Roche Diagnostics QPCR system

Archive

Recent Posts

  • Worldwide unique test for cervical cancer as a gamechanger for the healthcare system
  • Jena Biotechnology Company Files for Insolvency
  • Bachelor thesis in biotechnology companies: From research to diagnostics 

Epitype GmbH

The Epitype GmbH, a spin-off of the University Hospital Jena, is a company working on molecular diagnostics with main focus on the development of in-vitro diagnostics based on epigenetic biomarkers.

Epitype GmbH is working according to ISO 13485 standards in research, development, production and management.

Recent Posts

  • Worldwide unique test for cervical cancer as a gamechanger for the healthcare system
  • Jena Biotechnology Company Files for Insolvency
  • Bachelor thesis in biotechnology companies: From research to diagnostics 

Contact

Epitype GmbH
Löbstedter Str. 41
07749 Jena
Germany

Phone: +49 (0)3641 5548500

Email: contact[at]epitype.de
Internet: www.epitype.de

© 2015 - 2025 Epitype GmbH Jena Germany
  • Start
  • Imprint
  • Contact Us
  • Privacy policy
Scroll to top

Cookies help us deliver our services. By using our services, you agree to our use of cookies.

Learn moreI accept

Cookie and Privacy Settings



How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.

Other external services

We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Google reCaptcha Settings:

Vimeo and Youtube video embeds:

Privacy Policy

You can read about our cookies and privacy settings in detail on our Privacy Policy Page.

Privacy policy
Einstellungen akzeptierenVerberge nur die Benachrichtigung
Epitype GmbH
Einwilligung verwalten

Um Ihnen ein optimales Erlebnis zu bieten, verwenden wir Technologien wie Cookies, um Geräteinformationen zu speichern und/oder darauf zuzugreifen. Wenn Sie diesen Technologien zustimmen, können wir Daten wie das Surfverhalten oder eindeutige IDs auf dieser Website verarbeiten. Wenn Sie Ihre Einwilligung nicht erteilen oder zurückziehen, können bestimmte Merkmale und Funktionen beeinträchtigt werden.

Funktional Always active
Die technische Speicherung oder der Zugang ist unbedingt erforderlich für den rechtmäßigen Zweck, die Nutzung eines bestimmten Dienstes zu ermöglichen, der vom Teilnehmer oder Nutzer ausdrücklich gewünscht wird, oder für den alleinigen Zweck, die Übertragung einer Nachricht über ein elektronisches Kommunikationsnetz durchzuführen.
Präferenzen
Die technische Speicherung oder der Zugriff ist für den rechtmäßigen Zweck der Speicherung von Präferenzen erforderlich, die nicht vom Abonnenten oder Benutzer angefordert wurden.
Statistiken
Die technische Speicherung oder der Zugriff, der ausschließlich zu statistischen Zwecken erfolgt. Die technische Speicherung oder der Zugriff, der ausschließlich zu anonymen statistischen Zwecken verwendet wird. Ohne eine Vorladung, die freiwillige Zustimmung deines Internetdienstanbieters oder zusätzliche Aufzeichnungen von Dritten können die zu diesem Zweck gespeicherten oder abgerufenen Informationen allein in der Regel nicht dazu verwendet werden, dich zu identifizieren.
Marketing
Die technische Speicherung oder der Zugriff ist erforderlich, um Nutzerprofile zu erstellen, um Werbung zu versenden oder um den Nutzer auf einer Website oder über mehrere Websites hinweg zu ähnlichen Marketingzwecken zu verfolgen.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
Einstellungen ansehen
  • {title}
  • {title}
  • {title}